SPOP and prostate cancer: This study showed that in LHMAR and LNCaP cell lines, SPOP mutant-related or vector-based overexpression of DEK significantly promotes cell invasion and knockdown of DEK decreases cell invasion of cells overexpressing mutant SPOP, which implicates DEK as an oncogenic effector in prostate cancer.